{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:01:45Z","timestamp":1793826105281,"version":"4.6.1"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009017","name":"ALS Society of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009408","name":"Brain Canada","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009408","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100014505","name":"R. Howard Webster Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014505","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Canadian Consortium for Neurodegeneration in Aging"},{"DOI":"10.13039\/100008714","name":"Motor Neurone Disease Research Institute of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008714","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014012","name":"FightMND","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001777","name":"The University of Wollongong","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001777","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mutant superoxide dismutase 1 (SOD1) can be constitutively released from motor neurons and transmitted to na\u00efve motor neurons to promote the progression of amyotrophic lateral sclerosis (ALS). However, the biological impacts of this process and the precise mechanisms of SOD1 release remain to be fully resolved. Using biochemical and fluorescent techniques, this study aimed to determine if P2X7 receptor activation could induce mutant SOD1 release from motor neurons and whether this released SOD1 could be transmitted to motor neurons or microglia to mediate effects associated with neurodegeneration in ALS. Aggregated SOD1<jats:sup>G93A<\/jats:sup>, released from murine NSC-34 motor neurons transiently transfected with SOD1<jats:sup>G93A<\/jats:sup>, could be transmitted to na\u00efve NSC-34 cells and murine EOC13 microglia to induce endoplasmic reticulum (ER) stress and tumour necrosis factor-alpha (TNF\u03b1) release, respectively. Immunoblotting revealed NSC-34 cells expressed P2X7. Extracellular ATP induced cation dye uptake into these cells, which was blocked by the P2X7 antagonist AZ10606120, demonstrating these cells express functional P2X7. Moreover, ATP induced the rapid release of aggregated SOD1<jats:sup>G93A<\/jats:sup> from NSC-34 cells transiently transfected with SOD1<jats:sup>G93A<\/jats:sup>, a process blocked by AZ10606120 and revealing a role for P2X7 in this process. ATP-induced SOD1<jats:sup>G93A<\/jats:sup> release coincided with membrane blebbing. Finally, aggregated SOD1<jats:sup>G93A<\/jats:sup> released via P2X7 activation could also be transmitted to NSC-34 and EOC13 cells to induce ER stress and TNF\u03b1 release, respectively. Collectively, these results identify a novel role for P2X7 in the prion-like propagation of SOD1 in ALS and provide a possible explanation for the therapeutic benefits of P2X7 antagonism previously observed in ALS SOD1<jats:sup>G93A<\/jats:sup> mice.<\/jats:p>","DOI":"10.1007\/s11302-022-09863-5","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T04:45:00Z","timestamp":1651121100000},"page":"451-467","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["P2X7 receptor activation mediates superoxide dismutase 1 (SOD1) release from murine NSC-34 motor neurons"],"prefix":"10.1007","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9199-1326","authenticated-orcid":false,"given":"Rachael","family":"Bartlett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8454-1810","authenticated-orcid":false,"given":"Diane","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0080-1006","authenticated-orcid":false,"given":"Neil R.","family":"Cashman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4909-686X","authenticated-orcid":false,"given":"Ronald","family":"Sluyter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2528-7039","authenticated-orcid":false,"given":"Justin J.","family":"Yerbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,28]]},"reference":[{"key":"9863_CR1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1056\/NEJMra1603471","volume":"377","author":"RH Brown","year":"2017","unstructured":"Brown RH, Al-Chalabi A (2017) Amyotrophic lateral sclerosis. N Engl J Med 377:162\u2013172. https:\/\/doi.org\/10.1056\/NEJMra1603471","journal-title":"N Engl J Med"},{"key":"9863_CR2","doi-asserted-by":"publisher","unstructured":"Grad LI, Rouleau GA, Ravits J, Cashman NR (2017) Clinical spectrum of amyotrophic lateral sclerosis (ALS). Cold Spring Harb Perspect Med 7:a024117. https:\/\/doi.org\/10.1101\/cshperspect.a024117","DOI":"10.1101\/cshperspect.a024117"},{"key":"9863_CR3","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fnmol.2019.00262","volume":"12","author":"L McAlary","year":"2019","unstructured":"McAlary L, Plotkin SS, Yerbury JJ, Cashman NR (2019) Prion-like propagation of protein misfolding and aggregation in amyotrophic lateral sclerosis. Front Mol Neurosci 12:262. https:\/\/doi.org\/10.3389\/fnmol.2019.00262","journal-title":"Front Mol Neurosci"},{"key":"9863_CR4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/bs.pmbts.2020.07.002","volume":"175","author":"L McAlary","year":"2020","unstructured":"McAlary L, Yerbury JJ, Cashman NR (2020) The prion-like nature of amyotrophic lateral sclerosis. Prog Mol Biol Transl Sci 175:261\u2013296. https:\/\/doi.org\/10.1016\/bs.pmbts.2020.07.002","journal-title":"Prog Mol Biol Transl Sci"},{"key":"9863_CR5","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1126\/science.8209258","volume":"264","author":"ME Gurney","year":"1994","unstructured":"Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX et al (1994) Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264:1772\u20131775. https:\/\/doi.org\/10.1126\/science.8209258","journal-title":"Science"},{"key":"9863_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/362059a0","volume":"362","author":"DR Rosen","year":"1993","unstructured":"Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O\u2019Regan JP, Deng HX et al (1993) Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59\u201362. https:\/\/doi.org\/10.1038\/362059a0","journal-title":"Nature"},{"key":"9863_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.gene.2015.11.049","volume":"577","author":"SJ Kaur","year":"2016","unstructured":"Kaur SJ, McKeown SR, Rashid S (2016) Mutant SOD1 mediated pathogenesis of amyotrophic lateral sclerosis. Gene 577:109\u2013118. https:\/\/doi.org\/10.1016\/j.gene.2015.11.049","journal-title":"Gene"},{"key":"9863_CR8","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.1073\/pnas.1017275108","volume":"108","author":"C M\u00fcnch","year":"2011","unstructured":"M\u00fcnch C, O\u2019Brien J, Bertolotti A (2011) Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc Natl Acad Sci U S A 108:3548\u20133553. https:\/\/doi.org\/10.1073\/pnas.1017275108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9863_CR9","doi-asserted-by":"publisher","first-page":"16398","DOI":"10.1073\/pnas.1102645108","volume":"108","author":"LI Grad","year":"2011","unstructured":"Grad LI, Guest WC, Yanai A, Pokrishevsky E, O\u2019Neill MA, Gibbs E, Semenchenko V, Yousefi M, Wishart DS, Plotkin SS, Cashman NR (2011) Intermolecular transmission of superoxide dismutase 1 misfolding in living cells. Proc Natl Acad Sci U S A 108:16398\u201316403. https:\/\/doi.org\/10.1073\/pnas.1102645108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9863_CR10","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.1073\/pnas.1312245111","volume":"111","author":"LI Grad","year":"2014","unstructured":"Grad LI, Yerbury JJ, Turner BJ, Guest WC, Pokrishevsky E, O\u2019Neill MA, Yanai A, Silverman JM, Zeineddine R, Corcoran L, Kumita JR, Luheshi LM, Yousefi M, Coleman BM, Hill AF, Plotkin SS, Mackenzie IR, Cashman NR (2014) Intercellular propagated misfolding of wild-type Cu\/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms. Proc Natl Acad Sci U S A 111:3620\u20133625. https:\/\/doi.org\/10.1073\/pnas.1312245111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9863_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13024-015-0053-4","volume":"10","author":"R Zeineddine","year":"2015","unstructured":"Zeineddine R, Pundavela JF, Corcoran L, Stewart EM, Do-Ha D, Bax M, Guillemin G, Vine KL, Hatters DM, Ecroyd H, Dobson CM, Turner BJ, Ooi L, Wilson MR, Cashman NR, Yerbury JJ (2015) SOD1 protein aggregates stimulate macropinocytosis in neurons to facilitate their propagation. Mol Neurodegener 10:57. https:\/\/doi.org\/10.1186\/s13024-015-0053-4","journal-title":"Mol Neurodegener"},{"key":"9863_CR12","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00401-016-1623-4","volume":"132","author":"JI Ayers","year":"2016","unstructured":"Ayers JI, Diamond J, Sari A, Fromholt S, Galaleldeen A, Ostrow LW, Glass JD, Hart PJ, Borchelt DR (2016) Distinct conformers of transmissible misfolded SOD1 distinguish human SOD1-FALS from other forms of familial and sporadic ALS. Acta Neuropathol 132:827\u2013840. https:\/\/doi.org\/10.1007\/s00401-016-1623-4","journal-title":"Acta Neuropathol"},{"key":"9863_CR13","doi-asserted-by":"publisher","first-page":"e0227655","DOI":"10.1371\/journal.pone.0227655","volume":"15","author":"A Crown","year":"2020","unstructured":"Crown A, McAlary L, Fagerli E, Brown H, Yerbury JJ, Galaleldeen A, Cashman NR, Borchelt DR, Ayers JI (2020) Tryptophan residue 32 in human Cu-Zn superoxide dismutase modulates prion-like propagation and strain selection. PLoS ONE 15:e0227655. https:\/\/doi.org\/10.1371\/journal.pone.0227655","journal-title":"PLoS ONE"},{"key":"9863_CR14","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s00401-014-1342-7","volume":"128","author":"JI Ayers","year":"2014","unstructured":"Ayers JI, Fromholt S, Koch M, DeBosier A, McMahon B, Xu G, Borchelt DR (2014) Experimental transmissibility of mutant SOD1 motor neuron disease. Acta Neuropathol 128:791\u2013803. https:\/\/doi.org\/10.1007\/s00401-014-1342-7","journal-title":"Acta Neuropathol"},{"key":"9863_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neulet.2007.09.024","volume":"428","author":"C Gomes","year":"2007","unstructured":"Gomes C, Keller S, Altevogt P, Costa J (2007) Evidence for secretion of Cu, Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis. Neurosci Lett 428:43\u201346. https:\/\/doi.org\/10.1016\/j.neulet.2007.09.024","journal-title":"Neurosci Lett"},{"key":"9863_CR16","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.1007\/s00018-013-1385-2","volume":"70","author":"V Sundaramoorthy","year":"2013","unstructured":"Sundaramoorthy V, Walker AK, Yerbury J, Soo KY, Farg MA, Hoang V, Zeineddine R, Spencer D, Atkin JD (2013) Extracellular wildtype and mutant SOD1 induces ER-Golgi pathology characteristic of amyotrophic lateral sclerosis in neuronal cells. Cell Mol Life Sci 70:4181\u20134195. https:\/\/doi.org\/10.1007\/s00018-013-1385-2","journal-title":"Cell Mol Life Sci"},{"key":"9863_CR17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/glia.22444","volume":"61","author":"K Roberts","year":"2013","unstructured":"Roberts K, Zeineddine R, Corcoran L, Li W, Campbell IL, Yerbury JJ (2013) Extracellular aggregated Cu\/Zn superoxide dismutase activates microglia to give a cytotoxic phenotype. Glia 61:409\u2013419. https:\/\/doi.org\/10.1002\/glia.22444","journal-title":"Glia"},{"key":"9863_CR18","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s11302-021-09790-x","volume":"17","author":"LH Jiang","year":"2021","unstructured":"Jiang LH, Caseley EA, Muench SP, Roger S (2021) Structural basis for the functional properties of the P2X7 receptor for extracellular ATP. Purinergic Signal 17:331\u2013344. https:\/\/doi.org\/10.1007\/s11302-021-09790-x","journal-title":"Purinergic Signal"},{"key":"9863_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/5584_2017_59","volume":"1051","author":"R Sluyter","year":"2017","unstructured":"Sluyter R (2017) The P2X7 Receptor. Adv Exp Med Biol 1051:17\u201353. https:\/\/doi.org\/10.1007\/5584_2017_59","journal-title":"Adv Exp Med Biol"},{"key":"9863_CR20","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fnmol.2020.00124","volume":"13","author":"R Andrejew","year":"2020","unstructured":"Andrejew R, Oliveira-Giacomelli \u00c1, Ribeiro DE, Glaser T, Arnaud-Sampaio VF, Lameu C, Ulrich H (2020) The P2X7 receptor: central hub of brain diseases. Front Mol Neurosci 13:124. https:\/\/doi.org\/10.3389\/fnmol.2020.00124","journal-title":"Front Mol Neurosci"},{"key":"9863_CR21","doi-asserted-by":"publisher","first-page":"617036","DOI":"10.3389\/fncel.2021.617036","volume":"15","author":"PR Territo","year":"2021","unstructured":"Territo PR, Zarrinmayeh H (2021) P2X7 receptors in neurodegeneration: potential therapeutic applications from basic to clinical approaches. Front Cell Neurosci 15:617036. https:\/\/doi.org\/10.3389\/fncel.2021.617036","journal-title":"Front Cell Neurosci"},{"key":"9863_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fnmol.2020.00093","volume":"13","author":"C Ruiz-Ruiz","year":"2020","unstructured":"Ruiz-Ruiz C, Calzaferri F, Garc\u00eda AG (2020) P2X7 receptor antagonism as a potential therapy in amyotrophic lateral sclerosis. Front Mol Neurosci 13:93. https:\/\/doi.org\/10.3389\/fnmol.2020.00093","journal-title":"Front Mol Neurosci"},{"key":"9863_CR23","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.3389\/fphar.2020.01148","volume":"11","author":"C Volont\u00e9","year":"2020","unstructured":"Volont\u00e9 C, Amadio S, Liguori F, Fabbrizio P (2020) Duality of P2X7 receptor in amyotrophic lateral sclerosis. Front Pharmacol 11:1148. https:\/\/doi.org\/10.3389\/fphar.2020.01148","journal-title":"Front Pharmacol"},{"key":"9863_CR24","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1242\/dmm.017038","volume":"7","author":"S Apolloni","year":"2014","unstructured":"Apolloni S, Amadio S, Parisi C, Matteucci A, Potenza RL, Armida M, Popoli P, D\u2019Ambrosi N, Volont\u00e9 C (2014) Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis. Dis Model Mech 7:1101\u20131109. https:\/\/doi.org\/10.1242\/dmm.017038","journal-title":"Dis Model Mech"},{"key":"9863_CR25","doi-asserted-by":"publisher","first-page":"e3064","DOI":"10.7717\/peerj.3064","volume":"5","author":"R Bartlett","year":"2017","unstructured":"Bartlett R, Sluyter V, Watson D, Sluyter R, Yerbury JJ (2017) P2X7 antagonism using Brilliant Blue G reduces body weight loss and prolongs survival in female SOD1(G93A) amyotrophic lateral sclerosis mice. PeerJ 5:e3064. https:\/\/doi.org\/10.7717\/peerj.3064","journal-title":"PeerJ"},{"key":"9863_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.tox.2013.04.004","volume":"311","author":"C Cervetto","year":"2013","unstructured":"Cervetto C, Frattaroli D, Maura G, Marcoli M (2013) Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism. Toxicology 311:69\u201377. https:\/\/doi.org\/10.1016\/j.tox.2013.04.004","journal-title":"Toxicology"},{"key":"9863_CR27","doi-asserted-by":"publisher","unstructured":"Ruiz-Ruiz C, Garc\u00eda-Magro N, Negredo P, Avenda\u00f1o C, Bhattacharya A, Ceusters M, Garc\u00eda AG (2020) Chronic administration of P2X7 receptor antagonist JNJ-47965567 delays disease onset and progression, and improves motor performance in ALS SOD1(G93A) female mice. Dis Model Mech 13:dmm045732. https:\/\/doi.org\/10.1242\/dmm.045732","DOI":"10.1242\/dmm.045732"},{"key":"9863_CR28","doi-asserted-by":"publisher","first-page":"22586","DOI":"10.1038\/srep22586","volume":"6","author":"C de Torre-Minguela","year":"2016","unstructured":"de Torre-Minguela C, Barber\u00e0-Cremades M, G\u00f3mez AI, Mart\u00edn-S\u00e1nchez F, Pelegr\u00edn P (2016) Macrophage activation and polarization modify P2X7 receptor secretome influencing the inflammatory process. Sci Rep 6:22586. https:\/\/doi.org\/10.1038\/srep22586","journal-title":"Sci Rep"},{"key":"9863_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/icb.2014.69","volume":"93","author":"A Pupovac","year":"2015","unstructured":"Pupovac A, Geraghty NJ, Watson D, Sluyter R (2015) Activation of the P2X7 receptor induces the rapid shedding of CD23 from human and murine B cells. Immunol Cell Biol 93:77\u201385. https:\/\/doi.org\/10.1038\/icb.2014.69","journal-title":"Immunol Cell Biol"},{"key":"9863_CR30","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.imlet.2015.08.002","volume":"167","author":"T Takenouchi","year":"2015","unstructured":"Takenouchi T, Tsukimoto M, Iwamaru Y, Sugama S, Sekiyama K, Sato M, Kojima S, Hashimoto M, Kitani H (2015) Extracellular ATP induces unconventional release of glyceraldehyde-3-phosphate dehydrogenase from microglial cells. Immunol Lett 167:116\u2013124. https:\/\/doi.org\/10.1016\/j.imlet.2015.08.002","journal-title":"Immunol Lett"},{"key":"9863_CR31","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1111\/j.1471-4159.2012.07868.x","volume":"122","author":"K Nishida","year":"2012","unstructured":"Nishida K, Nakatani T, Ohishi A, Okuda H, Higashi Y, Matsuo T, Fujimoto S, Nagasawa K (2012) Mitochondrial dysfunction is involved in P2X7 receptor-mediated neuronal cell death. J Neurochem 122:1118\u20131128. https:\/\/doi.org\/10.1111\/j.1471-4159.2012.07868.x","journal-title":"J Neurochem"},{"key":"9863_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/aja.1001940306","volume":"194","author":"NR Cashman","year":"1992","unstructured":"Cashman NR, Durham HD, Blusztajn JK, Oda K, Tabira T, Shaw IT, Dahrouge S, Antel JP (1992) Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev Dyn 194:209\u2013221. https:\/\/doi.org\/10.1002\/aja.1001940306","journal-title":"Dev Dyn"},{"key":"9863_CR33","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1523\/jneurosci.4253-04.2005","volume":"25","author":"BJ Turner","year":"2005","unstructured":"Turner BJ, Atkin JD, Farg MA, Zang DW, Rembach A, Lopes EC, Patch JD, Hill AF, Cheema SS (2005) Impaired extracellular secretion of mutant superoxide dismutase 1 associates with neurotoxicity in familial amyotrophic lateral sclerosis. J Neurosci 25:108\u2013117. https:\/\/doi.org\/10.1523\/jneurosci.4253-04.2005","journal-title":"J Neurosci"},{"key":"9863_CR34","doi-asserted-by":"publisher","first-page":"271813","DOI":"10.1155\/2013\/271813","volume":"2013","author":"R Bartlett","year":"2013","unstructured":"Bartlett R, Yerbury JJ, Sluyter R (2013) P2X7 receptor activation induces reactive oxygen species formation and cell death in murine EOC13 microglia. Mediators Inflamm 2013:271813. https:\/\/doi.org\/10.1155\/2013\/271813","journal-title":"Mediators Inflamm"},{"key":"9863_CR35","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9:671\u2013675. https:\/\/doi.org\/10.1038\/nmeth.2089","journal-title":"Nat Methods"},{"key":"9863_CR36","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nm970","volume":"10","author":"T Iwawaki","year":"2004","unstructured":"Iwawaki T, Akai R, Kohno K, Miura M (2004) A transgenic mouse model for monitoring endoplasmic reticulum stress. Nat Med 10:98\u2013102. https:\/\/doi.org\/10.1038\/nm970","journal-title":"Nat Med"},{"key":"9863_CR37","doi-asserted-by":"publisher","first-page":"15590","DOI":"10.1038\/s41598-018-32835-y","volume":"8","author":"E Pokrishevsky","year":"2018","unstructured":"Pokrishevsky E, McAlary L, Farrawell NE, Zhao B, Sher M, Yerbury JJ, Cashman NR (2018) Tryptophan 32-mediated SOD1 aggregation is attenuated by pyrimidine-like compounds in living cells. Sci Rep 8:15590. https:\/\/doi.org\/10.1038\/s41598-018-32835-y","journal-title":"Sci Rep"},{"key":"9863_CR38","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.3892\/etm.2016.3130","volume":"11","author":"G Keilhoff","year":"2016","unstructured":"Keilhoff G, Lucas B, Uhde K, Fansa H (2016) Selected gene profiles of stressed NSC-34 cells and rat spinal cord following peripheral nerve reconstruction and minocycline treatment. Exp Ther Med 11:1685\u20131699. https:\/\/doi.org\/10.3892\/etm.2016.3130","journal-title":"Exp Ther Med"},{"key":"9863_CR39","doi-asserted-by":"publisher","first-page":"E1102","DOI":"10.1073\/pnas.1215177110","volume":"110","author":"MC Franco","year":"2013","unstructured":"Franco MC, Ye Y, Refakis CA, Feldman JL, Stokes AL, Basso M, Fern\u00e1ndez M, de Mera RM, Sparrow NA, Calingasan NY, Kiaei M, Rhoads TW, Ma TC, Grumet M, Barnes S, Beal MF, Beckman JS, Mehl R, Est\u00e9vez AG (2013) Nitration of Hsp90 induces cell death. Proc Natl Acad Sci U S A 110:E1102-1111. https:\/\/doi.org\/10.1073\/pnas.1215177110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9863_CR40","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/jnc.12286","volume":"126","author":"M Gandelman","year":"2013","unstructured":"Gandelman M, Levy M, Cassina P, Barbeito L, Beckman JS (2013) P2X7 receptor-induced death of motor neurons by a peroxynitrite\/FAS-dependent pathway. J Neurochem 126:382\u2013388. https:\/\/doi.org\/10.1111\/jnc.12286","journal-title":"J Neurochem"},{"key":"9863_CR41","doi-asserted-by":"publisher","first-page":"e93058","DOI":"10.1371\/journal.pone.0093058","volume":"9","author":"A Bhaskaracharya","year":"2014","unstructured":"Bhaskaracharya A, Dao-Ung P, Jalilian I, Spildrejorde M, Skarratt KK, Fuller SJ, Sluyter R, Stokes L (2014) Probenecid blocks human P2X7 receptor-induced dye uptake via a pannexin-1 independent mechanism. PLoS ONE 9:e93058. https:\/\/doi.org\/10.1371\/journal.pone.0093058","journal-title":"PLoS ONE"},{"key":"9863_CR42","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/sj.bjp.0707196","volume":"151","author":"AD Michel","year":"2007","unstructured":"Michel AD, Chambers LJ, Clay WC, Condreay JP, Walter DS, Chessell IP (2007) Direct labelling of the human P2X7 receptor and identification of positive and negative cooperativity of binding. Br J Pharmacol 151:103\u2013114. https:\/\/doi.org\/10.1038\/sj.bjp.0707196","journal-title":"Br J Pharmacol"},{"key":"9863_CR43","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/s41419-019-2110-3","volume":"10","author":"S Bidula","year":"2019","unstructured":"Bidula S, Dhuna K, Helliwell R, Stokes L (2019) Positive allosteric modulation of P2X7 promotes apoptotic cell death over lytic cell death responses in macrophages. Cell Death Dis 10:882. https:\/\/doi.org\/10.1038\/s41419-019-2110-3","journal-title":"Cell Death Dis"},{"key":"9863_CR44","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1074\/jbc.M605620200","volume":"282","author":"N Panupinthu","year":"2007","unstructured":"Panupinthu N, Zhao L, Possmayer F, Ke HZ, Sims SM, Dixon SJ (2007) P2X7 nucleotide receptors mediate blebbing in osteoblasts through a pathway involving lysophosphatidic acid. J Biol Chem 282:3403\u20133412. https:\/\/doi.org\/10.1074\/jbc.M605620200","journal-title":"J Biol Chem"},{"key":"9863_CR45","doi-asserted-by":"publisher","first-page":"5728","DOI":"10.4049\/jimmunol.170.11.5728","volume":"170","author":"PA Verhoef","year":"2003","unstructured":"Verhoef PA, Estacion M, Schilling W, Dubyak GR (2003) P2X7 receptor-dependent blebbing and the activation of Rho-effector kinases, caspases, and IL-1 beta release. J Immunol 170:5728\u20135738. https:\/\/doi.org\/10.4049\/jimmunol.170.11.5728","journal-title":"J Immunol"},{"issue":"Pt 2","key":"9863_CR46","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1469-7793.1999.0335m.x","volume":"519","author":"C Virginio","year":"1999","unstructured":"Virginio C, MacKenzie A, North RA, Surprenant A (1999) Kinetics of cell lysis, dye uptake and permeability changes in cells expressing the rat P2X7 receptor. J Physiol 519(Pt 2):335\u2013346. https:\/\/doi.org\/10.1111\/j.1469-7793.1999.0335m.x","journal-title":"J Physiol"},{"key":"9863_CR47","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/jcb.23425","volume":"113","author":"A Kirov","year":"2012","unstructured":"Kirov A, Al-Hashimi H, Solomon P, Mazur C, Thorpe PE, Sims PJ, Tarantini F, Kumar TK, Prudovsky I (2012) Phosphatidylserine externalization and membrane blebbing are involved in the nonclassical export of FGF1. J Cell Biochem 113:956\u2013966. https:\/\/doi.org\/10.1002\/jcb.23425","journal-title":"J Cell Biochem"},{"key":"9863_CR48","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41598-017-00732-5","volume":"7","author":"RC Allsopp","year":"2017","unstructured":"Allsopp RC, Dayl S, Schmid R, Evans RJ (2017) Unique residues in the ATP gated human P2X7 receptor define a novel allosteric binding pocket for the selective antagonist AZ10606120. Sci Rep 7:725. https:\/\/doi.org\/10.1038\/s41598-017-00732-5","journal-title":"Sci Rep"},{"key":"9863_CR49","doi-asserted-by":"publisher","unstructured":"Karasawa A, Kawate T (2016) Structural basis for subtype-specific inhibition of the P2X7 receptor. eLife 5:e22153. https:\/\/doi.org\/10.7554\/eLife.22153","DOI":"10.7554\/eLife.22153"},{"key":"9863_CR50","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/bph.15299","volume":"178","author":"P Illes","year":"2021","unstructured":"Illes P, M\u00fcller CE, Jacobson KA, Grutter T, Nicke A, Fountain SJ, Kennedy C, Schmalzing G, Jarvis MF, Stojilkovic SS, King BF, Di Virgilio F (2021) Update of P2X receptor properties and their pharmacology: IUPHAR Review 30. Br J Pharmacol 178:489\u2013514. https:\/\/doi.org\/10.1111\/bph.15299","journal-title":"Br J Pharmacol"},{"key":"9863_CR51","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10571-015-0294-3","volume":"36","author":"JM Silverman","year":"2016","unstructured":"Silverman JM, Fernando SM, Grad LI, Hill AF, Turner BJ, Yerbury JJ, Cashman NR (2016) Disease mechanisms in ALS: misfolded SOD1 transferred through exosome-dependent and exosome-independent pathways. Cell Mol Neurobiol 36:377\u2013381. https:\/\/doi.org\/10.1007\/s10571-015-0294-3","journal-title":"Cell Mol Neurobiol"},{"key":"9863_CR52","doi-asserted-by":"publisher","first-page":"4648","DOI":"10.4049\/jimmunol.0901212","volume":"183","author":"N D'Ambrosi","year":"2009","unstructured":"D\u2019Ambrosi N, Finocchi P, Apolloni S, Cozzolino M, Ferri A, Padovano V, Pietrini G, Carr\u00ec MT, Volont\u00e9 C (2009) The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis. J Immunol 183:4648\u20134656. https:\/\/doi.org\/10.4049\/jimmunol.0901212","journal-title":"J Immunol"},{"key":"9863_CR53","doi-asserted-by":"publisher","first-page":"6245","DOI":"10.1038\/ncomms7245","volume":"6","author":"J Ousingsawat","year":"2015","unstructured":"Ousingsawat J, Wanitchakool P, Kmit A, Romao AM, Jantarajit W, Schreiber R, Kunzelmann K (2015) Anoctamin 6 mediates effects essential for innate immunity downstream of P2X7 receptors in macrophages. Nat Commun 6:6245. https:\/\/doi.org\/10.1038\/ncomms7245","journal-title":"Nat Commun"},{"key":"9863_CR54","doi-asserted-by":"publisher","first-page":"33968","DOI":"10.1074\/jbc.M502705200","volume":"280","author":"AB Mackenzie","year":"2005","unstructured":"Mackenzie AB, Young MT, Adinolfi E, Surprenant A (2005) Pseudoapoptosis induced by brief activation of ATP-gated P2X7 receptors. J Biol Chem 280:33968\u201333976. https:\/\/doi.org\/10.1074\/jbc.M502705200","journal-title":"J Biol Chem"},{"key":"9863_CR55","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1091\/mbc.02-04-0061","volume":"14","author":"A Morelli","year":"2003","unstructured":"Morelli A, Chiozzi P, Chiesa A, Ferrari D, Sanz JM, Falzoni S, Pinton P, Rizzuto R, Olson MF, Di Virgilio F (2003) Extracellular ATP causes ROCK I-dependent bleb formation in P2X7-transfected HEK293 cells. Mol Biol Cell 14:2655\u20132664. https:\/\/doi.org\/10.1091\/mbc.02-04-0061","journal-title":"Mol Biol Cell"},{"key":"9863_CR56","doi-asserted-by":"publisher","unstructured":"Apolloni S, Fabbrizio P, Amadio S, Napoli G, Freschi M, Sironi F, Pevarello P, Tarroni P, Liberati C, Bendotti C, Volont\u00e9 C (2021) Novel P2X7 antagonist ameliorates the early phase of ALS disease and decreases inflammation and autophagy in SOD1-G93A mouse model. Int J Mol Sci 22:10649. https:\/\/doi.org\/10.3390\/ijms221910649","DOI":"10.3390\/ijms221910649"},{"key":"9863_CR57","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3389\/fncel.2017.00249","volume":"11","author":"P Fabbrizio","year":"2017","unstructured":"Fabbrizio P, Amadio S, Apolloni S, Volont\u00e9 C (2017) P2X7 receptor activation modulates autophagy in SOD1-G93A mouse microglia. Front Cell Neurosci 11:249. https:\/\/doi.org\/10.3389\/fncel.2017.00249","journal-title":"Front Cell Neurosci"},{"key":"9863_CR58","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1074\/jbc.270.7.3234","volume":"270","author":"DR Borchelt","year":"1995","unstructured":"Borchelt DR, Guarnieri M, Wong PC, Lee MK, Slunt HS, Xu ZS, Sisodia SS, Price DL, Cleveland DW (1995) Superoxide dismutase 1 subunits with mutations linked to familial amyotrophic lateral sclerosis do not affect wild-type subunit function. J Biol Chem 270:3234\u20133238. https:\/\/doi.org\/10.1074\/jbc.270.7.3234","journal-title":"J Biol Chem"},{"key":"9863_CR59","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1172\/jci80705","volume":"125","author":"MJ Crisp","year":"2015","unstructured":"Crisp MJ, Mawuenyega KG, Patterson BW, Reddy NC, Chott R, Self WK, Weihl CC, Jockel-Balsarotti J, Varadhachary AS, Bucelli RC, Yarasheski KE, Bateman RJ, Miller TM (2015) In vivo kinetic approach reveals slow SOD1 turnover in the CNS. J Clin Invest 125:2772\u20132780. https:\/\/doi.org\/10.1172\/jci80705","journal-title":"J Clin Invest"},{"key":"9863_CR60","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1111\/cmi.12001","volume":"14","author":"GR Dubyak","year":"2012","unstructured":"Dubyak GR (2012) P2X7 receptor regulation of non-classical secretion from immune effector cells. Cell Microbiol 14:1697\u20131706. https:\/\/doi.org\/10.1111\/cmi.12001","journal-title":"Cell Microbiol"},{"key":"9863_CR61","doi-asserted-by":"publisher","first-page":"e106389","DOI":"10.15252\/embj.2020106389","volume":"40","author":"ME Cicardi","year":"2021","unstructured":"Cicardi ME, Marrone L, Azzouz M, Trotti D (2021) Proteostatic imbalance and protein spreading in amyotrophic lateral sclerosis. EMBO J 40:e106389. https:\/\/doi.org\/10.15252\/embj.2020106389","journal-title":"EMBO J"},{"key":"9863_CR62","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.neulet.2016.04.066","volume":"636","author":"P Rozas","year":"2017","unstructured":"Rozas P, Bargsted L, Mart\u00ednez F, Hetz C, Medinas DB (2017) The ER proteostasis network in ALS: Determining the differential motoneuron vulnerability. Neurosci Lett 636:9\u201315. https:\/\/doi.org\/10.1016\/j.neulet.2016.04.066","journal-title":"Neurosci Lett"},{"key":"9863_CR63","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nn.2297","volume":"12","author":"S Saxena","year":"2009","unstructured":"Saxena S, Cabuy E, Caroni P (2009) A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat Neurosci 12:627\u2013636. https:\/\/doi.org\/10.1038\/nn.2297","journal-title":"Nat Neurosci"},{"key":"9863_CR64","doi-asserted-by":"publisher","first-page":"2985051","DOI":"10.1155\/2017\/2985051","volume":"2017","author":"M Tortarolo","year":"2017","unstructured":"Tortarolo M, Lo Coco D, Veglianese P, Vallarola A, Giordana MT, Marcon G, Beghi E, Poloni M, Strong MJ, Iyer AM, Aronica E, Bendotti C (2017) Amyotrophic lateral sclerosis, a multisystem pathology: insights into the role of TNF\u03b1. Mediators Inflamm 2017:2985051. https:\/\/doi.org\/10.1155\/2017\/2985051","journal-title":"Mediators Inflamm"},{"key":"9863_CR65","doi-asserted-by":"publisher","first-page":"7049","DOI":"10.1523\/jneurosci.3103-16.2017","volume":"37","author":"P Illes","year":"2017","unstructured":"Illes P, Khan TM, Rubini P (2017) Neuronal P2X7 receptors revisited: do they really exist? J Neurosci 37:7049\u20137062. https:\/\/doi.org\/10.1523\/jneurosci.3103-16.2017","journal-title":"J Neurosci"},{"key":"9863_CR66","doi-asserted-by":"publisher","first-page":"7063","DOI":"10.1523\/jneurosci.3104-16.2017","volume":"37","author":"MT Miras-Portugal","year":"2017","unstructured":"Miras-Portugal MT, Sebasti\u00e1n-Serrano \u00c1, de Diego GL, D\u00edaz-Hern\u00e1ndez M (2017) Neuronal P2X7 receptor: involvement in neuronal physiology and pathology. J Neurosci 37:7063\u20137072. https:\/\/doi.org\/10.1523\/jneurosci.3104-16.2017","journal-title":"J Neurosci"},{"key":"9863_CR67","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.brainres.2004.12.001","volume":"1034","author":"TS Moores","year":"2005","unstructured":"Moores TS, Hasdemir B, Vega-Riveroll L, Deuchars J, Parson SH (2005) Properties of presynaptic P2X7-like receptors at the neuromuscular junction. Brain Res 1034:40\u201350. https:\/\/doi.org\/10.1016\/j.brainres.2004.12.001","journal-title":"Brain Res"},{"key":"9863_CR68","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.brainres.2007.11.064","volume":"1194","author":"Y Yu","year":"2008","unstructured":"Yu Y, Ugawa S, Ueda T, Ishida Y, Inoue K, Kyaw Nyunt A, Umemura A, Mase M, Yamada K, Shimada S (2008) Cellular localization of P2X7 receptor mRNA in the rat brain. Brain Res 1194:45\u201355. https:\/\/doi.org\/10.1016\/j.brainres.2007.11.064","journal-title":"Brain Res"},{"key":"9863_CR69","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1046\/j.1471-4159.1998.70030951.x","volume":"70","author":"H Kaiho","year":"1998","unstructured":"Kaiho H, Matsuoka I, Kimura J, Nakanishi H (1998) Identification of P2X7 (P2Z) receptor in N18TG-2 cells and NG108-15 cells. J Neurochem 70:951\u2013957. https:\/\/doi.org\/10.1046\/j.1471-4159.1998.70030951.x","journal-title":"J Neurochem"},{"key":"9863_CR70","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11302-020-09692-4","volume":"16","author":"D Ly","year":"2020","unstructured":"Ly D, Dongol A, Cuthbertson P, Guy TV, Geraghty NJ, Sophocleous RA, Sin L, Turner BJ, Watson D, Yerbury JJ, Sluyter R (2020) The P2X7 receptor antagonist JNJ-47965567 administered thrice weekly from disease onset does not alter progression of amyotrophic lateral sclerosis in SOD1(G93A) mice. Purinergic Signal 16:109\u2013122. https:\/\/doi.org\/10.1007\/s11302-020-09692-4","journal-title":"Purinergic Signal"},{"key":"9863_CR71","doi-asserted-by":"publisher","first-page":"749","DOI":"10.4103\/1673-5374.206643","volume":"12","author":"R Sluyter","year":"2017","unstructured":"Sluyter R, Bartlett R, Ly D, Yerbury JJ (2017) P2X7 receptor antagonism in amyotrophic lateral sclerosis. Neural Regen Res 12:749\u2013750. https:\/\/doi.org\/10.4103\/1673-5374.206643","journal-title":"Neural Regen Res"},{"key":"9863_CR72","doi-asserted-by":"publisher","first-page":"4108","DOI":"10.4049\/jimmunol.169.8.4108","volume":"169","author":"S Adriouch","year":"2002","unstructured":"Adriouch S, Dox C, Welge V, Seman M, Koch-Nolte F, Haag F (2002) Cutting edge: a natural P451L mutation in the cytoplasmic domain impairs the function of the mouse P2X7 receptor. J Immunol 169:4108\u20134112. https:\/\/doi.org\/10.4049\/jimmunol.169.8.4108","journal-title":"J Immunol"},{"key":"9863_CR73","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1124\/pr.113.008003","volume":"66","author":"R Bartlett","year":"2014","unstructured":"Bartlett R, Stokes L, Sluyter R (2014) The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease. Pharmacol Rev 66:638\u2013675. https:\/\/doi.org\/10.1124\/pr.113.008003","journal-title":"Pharmacol Rev"},{"key":"9863_CR74","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0165-5728(95)00146-8","volume":"63","author":"WS Walker","year":"1995","unstructured":"Walker WS, Gatewood J, Olivas E, Askew D, Havenith CE (1995) Mouse microglial cell lines differing in constitutive and interferon-gamma-inducible antigen-presenting activities for naive and memory CD4+ and CD8+ T cells. J Neuroimmunol 63:163\u2013174. https:\/\/doi.org\/10.1016\/0165-5728(95)00146-8","journal-title":"J Neuroimmunol"},{"key":"9863_CR75","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nm.2710","volume":"18","author":"RE Sorge","year":"2012","unstructured":"Sorge RE, Trang T, Dorfman R, Smith SB, Beggs S, Ritchie J, Austin JS, Zaykin DV, Vander Meulen H, Costigan M, Herbert TA, Yarkoni-Abitbul M, Tichauer D, Livneh J, Gershon E, Zheng M, Tan K, John SL, Slade GD, Jordan J, Woolf CJ, Peltz G, Maixner W, Diatchenko L, Seltzer Z, Salter MW, Mogil JS (2012) Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity. Nat Med 18:595\u2013599. https:\/\/doi.org\/10.1038\/nm.2710","journal-title":"Nat Med"},{"key":"9863_CR76","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1073\/pnas.64.1.311","volume":"64","author":"G Augusti-Tocco","year":"1969","unstructured":"Augusti-Tocco G, Sato G (1969) Establishment of functional clonal lines of neurons from mouse neuroblastoma. Proc Natl Acad Sci U S A 64:311\u2013315. https:\/\/doi.org\/10.1073\/pnas.64.1.311","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9863_CR77","unstructured":"Murphy ED (1966) Characteristic Tumours. In: Green EL (ed) Biology of the Laboratory Mouse. Dover Publications, Inc., New York, Ch 27. http:\/\/www.informatics.jax.org\/greenbook\/frames\/frame27.shtml"},{"key":"9863_CR78","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/j.1476-5381.2009.00233.x","volume":"157","author":"DL Donnelly-Roberts","year":"2009","unstructured":"Donnelly-Roberts DL, Namovic MT, Han P, Jarvis MF (2009) Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors. Br J Pharmacol 157:1203\u20131214. https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00233.x","journal-title":"Br J Pharmacol"},{"key":"9863_CR79","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/sj.bjp.0706880","volume":"149","author":"MT Young","year":"2006","unstructured":"Young MT, Pelegrin P, Surprenant A (2006) Identification of Thr283 as a key determinant of P2X7 receptor function. Br J Pharmacol 149:261\u2013268. https:\/\/doi.org\/10.1038\/sj.bjp.0706880","journal-title":"Br J Pharmacol"},{"key":"9863_CR80","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/s0014-5793(98)01332-5","volume":"439","author":"IP Chessell","year":"1998","unstructured":"Chessell IP, Simon J, Hibell AD, Michel AD, Barnard EA, Humphrey PP (1998) Cloning and functional characterisation of the mouse P2X7 receptor. FEBS Lett 439:26\u201330. https:\/\/doi.org\/10.1016\/s0014-5793(98)01332-5","journal-title":"FEBS Lett"},{"key":"9863_CR81","doi-asserted-by":"publisher","first-page":"102105","DOI":"10.1016\/j.pneurobio.2021.102105","volume":"204","author":"E Beamer","year":"2021","unstructured":"Beamer E, Kuchukulla M, Boison D, Engel T (2021) ATP and adenosine-two players in the control of seizures and epilepsy development. Prog Neurobiol 204:102105. https:\/\/doi.org\/10.1016\/j.pneurobio.2021.102105","journal-title":"Prog Neurobiol"},{"key":"9863_CR82","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3389\/fnins.2017.00273","volume":"11","author":"S Pinto","year":"2017","unstructured":"Pinto S, Cunha C, Barbosa M, Vaz AR, Brites D (2017) Exosomes from NSC-34 Cells Transfected with hSOD1-G93A Are Enriched in miR-124 and Drive Alterations in Microglia Phenotype. Front Neurosci 11:273. https:\/\/doi.org\/10.3389\/fnins.2017.00273","journal-title":"Front Neurosci"},{"key":"9863_CR83","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s12974-021-02326-5","volume":"18","author":"YF Malada Edelstein","year":"2021","unstructured":"Malada Edelstein YF, Solomonov Y, Hadad N, Alfahel L, Israelson A, Levy R (2021) Early upregulation of cytosolic phospholipase A2\u03b1 in motor neurons is induced by misfolded SOD1 in a mouse model of amyotrophic lateral sclerosis. J Neuroinflammation 18:274. https:\/\/doi.org\/10.1186\/s12974-021-02326-5","journal-title":"J Neuroinflammation"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-022-09863-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-022-09863-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-022-09863-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T01:04:22Z","timestamp":1673399062000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11302-022-09863-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,28]]},"references-count":83,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["9863"],"URL":"https:\/\/doi.org\/10.1007\/s11302-022-09863-5","relation":{},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,28]]},"assertion":[{"value":"20 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study does not contain any work with animals or human participants performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors give their consent for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Rachael Bartlett declares no conflict of interest.Diane Ly declares no conflict of interest.Neil R. Cashman declares no conflict of interest.Ronald Sluyter declares no conflict of interest.Justin J. Yerbury declares no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}